Cognition Therapeutics
Cognition Therapeutics is a biotechnology and pharmaceutical company developing therapeutics for Alzheimer’s disease and other neurodegenerative disorders that is headquartered in Pittsburgh, Pennsylvania in 2007 by Gilbert Rishton and Susan Catalano.
Key facts
| AngelList URL | https://angel.co/cognition-therapeutics |
|---|---|
| CAGE Code | 5CQK3 |
| Legal Name | Cognition Therapeutics, Inc. |
| Company Operating Status | Active |
| Crunchbase URL | https://www.crunchbase.com/organization/cognition-therapeutics |
| Full Address | 2403 Sidney Street Pittsburgh, PA 15203 United States |
| LinkedIn URL | https://www.linkedin.com/company/cognition-therapeutics/ |
| Pitchbook URL | https://pitchbook.com/profiles/company/52104-79#overview |
| Public/Private | Public |
| Stock Symbol | CGTX |
| Ticker Symbol | CGTX |
| Twitter URL | https://twitter.com/cogrx |
| Official Website | http://cogrx.com |
| Wellfound ID | cognition-therapeutics |
| Wikidata ID | Q30287217 |
Contact details
Email and phone for Cognition Therapeutics are available to signed-in members of PharmaLyt.
Sign in to view